The Molecular Diversity Core has been existence in some form within the University of Washington CFAR for the past three years. To date it has serve a collaborative function housed within and centered around activities within the laboratories of the Core Director James I. Mullins and Co-director Leroy Hood, in collaboration with other members of the UW CFAR community, members of other National CFARs and non-CFAR affiliated AIDS researchers worldwide. These collaborations have resulted in 18 manuscripts and publications to date in areas ranging from development of algorithms for the conduct and quality control of virus sequencing studies, to whole viral genome analysis, HIV molecular epidemiology and HIV gene evolution in vivo. 44 additional projects are ongoing and for the past 1.5 years the Core has also operated at University wide Recharge Center for DNA Sequencing, Going forward, the Core will provide three basic functions within the UW CFAR community of investigators. 1 Perform DNA sequencing and quality control analyses of data (data edits and database searchers); 2 Train and collaborate with CFAR investigators in phylogenetic and bioinformatics based analyses; 3 Develop and make available new genetic technologies and computational tools. These include the heteroduplex mobility and tracking assays now available and high density oligonucleotide array based DNA sequencing methods now under development. Computational tools are being developed for viral sequencing project management and analysis, as new methods of analysis of viral populations and recombination. The core will be overseen by an Advisory Committee composed of the Core Directors and other CFAR members and will be coordinated by Gerald H. Learn and the CFAR Computational Biology Unit (CBU). Core funds will be used to pay portions of the salaries of Dr. Lean and the CFAR Computational Biology Unit (CBU). Core funds will be used to pay portions of the salaries of Dr. Lean and his assistant for sequence project management, as well as a programming specialist and two other investigators engaged in the development of new technologies and computational tools. The DNA sequencing Recharge Center will be supported entirely by a charge back mechanism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-12
Application #
6099410
Study Section
Project Start
1999-03-01
Project End
2000-02-29
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
12
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Katz, David A; Golden, Matthew R; Hughes, James P et al. (2018) HIV Self-Testing Increases HIV Testing Frequency in High-Risk Men Who Have Sex With Men: A Randomized Controlled Trial. J Acquir Immune Defic Syndr 78:505-512
Golob, Jonathan L; Stern, Joshua; Holte, Sarah et al. (2018) HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients. AIDS 32:2113-2118
Dombrowski, Julia C; Golden, Matthew R; Barbee, Lindley A et al. (2018) Patient Disengagement From an HIV Preexposure Prophylaxis Program in a Sexually Transmitted Disease Clinic. Sex Transm Dis 45:e62-e64
Heller, Madeleine; Roberts, Sarah T; Masese, Linnet et al. (2018) Gender-Based Violence, Physiological Stress, and Inflammation: A Cross-Sectional Study. J Womens Health (Larchmt) 27:1152-1161
Pyra, Maria; Anderson, Peter L; Hendrix, Craig W et al. (2018) Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis. AIDS 32:1891-1898
Wilson, Kate S; Wanje, George; Masese, Linnet et al. (2018) A Prospective Cohort Study of Fertility Desire, Unprotected Sex, and Detectable Viral Load in HIV-Positive Female Sex Workers in Mombasa, Kenya. J Acquir Immune Defic Syndr 78:276-282
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Fredericksen, Rob J; Mayer, Kenneth H; Gibbons, Laura E et al. (2018) Development and Content Validation of a Patient-Reported Sexual Risk Measure for Use in Primary Care. J Gen Intern Med 33:1661-1668
Gómez, Laurén A; Crowell, Claudia S; Njuguna, Irene et al. (2018) Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children. Pediatr Infect Dis J 37:916-922
Ikoma, Minako; Gantt, Soren; Casper, Corey et al. (2018) KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite. PLoS One 13:e0192659

Showing the most recent 10 out of 1275 publications